{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:04:54Z","timestamp":1783919094445,"version":"3.55.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013318","name":"Shanxi Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Tumor-induced osteomalacia (TIO) is an acquired hypophosphatemic osteodystrophy caused by increased renal phosphate excretion due to tumors. Tenosynovial giant cell tumor (TGCT) is a benign mesenchymal tumor but rarely causes hypophosphatemia. TIO is a clinically rare disease, and its clinical manifestations often overlap with rheumatic diseases such as spondyloarthritis (SpA), leading to misdiagnosis. A 32-year-old female had a prolonged misdiagnosis of undifferentiated spondyloarthritis due to chronic low back pain, limb weakness, and spinal deformity, with poor response to non-steroidal anti-inflammatory drugs and various biologic agents. After hospitalization, a systematic biochemical screening for metabolic bone disease revealed decreased serum phosphate, calcium, and 25-hydroxyvitamin D levels, along with elevated alkaline phosphatase. Subsequently, a previously undetected tumor in the right plantar region was successfully localized using 68Ga DOTA-TATE PET\/CT. After complete surgical removal of the tumor, the patient\u2019s serum phosphate levels rapidly returned to normal, and bone pain symptoms were significantly alleviated. After histopathological staining of the tumor, it was considered to be diffuse tenosynovial giant cell tumor (D-TGCT). This case clearly demonstrates a TIO caused by the rare disease D-TGCT. Its diagnosis and treatment journey not only reveals the clinical relevance of D-TGCT as an atypical pathogenic tumor but also highlights the critical importance of multidisciplinary collaboration and advanced diagnostic techniques in tackling such rare diseases. This provides clear guidance for enhancing clinical awareness and optimizing treatment strategies.<\/jats:p>","DOI":"10.3389\/fendo.2026.1808434","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T04:23:47Z","timestamp":1783916627000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypophosphatemic osteomalacia caused by diffuse tenosynovial giant cell tumor misdiagnosed as spondyloarthritis: a case report"],"prefix":"10.3389","volume":"17","author":[{"given":"Yazhen","family":"Su","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]},{"name":"Shanxi Province Clinical Research Center for Dermatologic and Immunologic Diseases (Rheumatic diseases)","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihong","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]},{"name":"Shanxi Province Clinical Research Center for Dermatologic and Immunologic Diseases (Rheumatic diseases)","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]},{"name":"Shanxi Province Clinical Research Center for Dermatologic and Immunologic Diseases (Rheumatic diseases)","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]},{"name":"Shanxi Province Clinical Research Center for Dermatologic and Immunologic Diseases (Rheumatic diseases)","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]},{"name":"Shanxi Province Clinical Research Center for Dermatologic and Immunologic Diseases (Rheumatic diseases)","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnac026","article-title":"Tumor-induced osteomalacia: a comprehensive review","volume":"44","author":"Minisola","year":"2023","journal-title":"Endocr Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad690","article-title":"Clinical characteristics of Malignant phosphaturic mesenchymal tumor causing tumor-induced osteomalacia","volume":"109","author":"Abate","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-022-01005-8","article-title":"Tumor-induced osteomalacia: a systematic clinical review of 895 cases","volume":"111","author":"Bosman","year":"2022","journal-title":"Calcif Tissue Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000002550","article-title":"Giant cell tumor of tendon sheath revealed on 68Ga-DOTA-TATE PET\/CT in a patient with suspicious tumor-induced osteomalacia","volume":"44","author":"Jia","year":"2019","journal-title":"Clin Nucl Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.5435\/JAAOS-D-24-01255","article-title":"Tenosynovial giant cell tumor and pigmented villonodular synovitis","volume":"33","author":"Kemp","year":"2025","journal-title":"J Am Acad Orthop Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ16-0587","article-title":"The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases","volume":"64","author":"Feng","year":"2017","journal-title":"Endocr J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jor.2016.12.010","article-title":"Musculoskeletal oncogenic osteomalacia-an experience from a single centre in South India","volume":"14","author":"Satyaraddi","year":"2017","journal-title":"J Orthop"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v7.i15.2081","article-title":"Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the femur: a case report","volume":"7","author":"Tang","year":"2019","journal-title":"World J Clin cases"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2018.0016","article-title":"Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia-diagnostic challenges and clinical outcomes","volume":"69","author":"Dutta","year":"2018","journal-title":"Endokrynol Pol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-021-01474-7","article-title":"Oncogenic osteomalacia: challenges in diagnosis","volume":"14","author":"Kothandaraman","year":"2023","journal-title":"Indian J Surg Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15507","article-title":"Renal phosphate wasting due to tumor-induced (oncogenic) osteomalacia","volume":"13","author":"Amaratunga","year":"2021","journal-title":"Cureus"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/02841851231160086","article-title":"Imaging characteristics of phosphaturic mesenchymal tumors","volume":"64","author":"Gupta","year":"2023","journal-title":"Acta Radiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/wjnm.WJNM_92_18","article-title":"68GaDOTATATE positron emission tomography\/computed tomographyto detect the recurrence of phosphaturic mesenhcymal tumorinducedosteomalacia","volume":"19","author":"Bhalla","year":"2020","journal-title":"World J Nucl Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14238451","article-title":"A comprehensive review of SSTR-based spect and pet imaging in chronic inflammatory and immune-mediated diseases","volume":"14","author":"Li","year":"2025","journal-title":"J Clin Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1097\/RLU.0000000000000460","article-title":"Comparison of 18F-FDG and 68Ga DOTATATE PET\/CT in localization of tumor causing oncogenic osteomalacia","volume":"40","author":"Agrawal","year":"2015","journal-title":"Clin Nucl Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/os.12980","article-title":"Comparison of 18 F-FDG PET\/CT and 68 Ga-DOTATATE PET\/CT in the targeted imaging of culprit tumors causing osteomalacia","volume":"13","author":"Yu","year":"2021","journal-title":"Orthop Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000000854","article-title":"68Ga DOTATATE PET\/CT is an accurate imaging modality in the detection of culprit tumors causing osteomalacia","volume":"40","author":"Zhang","year":"2015","journal-title":"Clin Nucl Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2017.58.5.981","article-title":"Localization of oncogenic osteomalacia by systemic venous sampling of fibroblast growth factor 23","volume":"58","author":"Lee","year":"2017","journal-title":"Yonsei Med J"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56010034","article-title":"Fibroblast growth factor 23-producing phosphaturic mesenchymal tumor with extraordinary morphology causing oncogenic osteomalacia","volume":"56","author":"Then","year":"2020","journal-title":"Medicina"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e328347e1e3","article-title":"Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis","volume":"23","author":"Ravi","year":"2011","journal-title":"Curr Opin Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.56215","article-title":"Giant cell tumor in tarsal midfoot bones: a case report","volume":"16","author":"Abed Alharbi","year":"2024","journal-title":"Cureus"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2023.1908","article-title":"Acquired forms of fibroblast growth factor 23-related hypophosphatemic osteomalacia","volume":"39","author":"Ito","year":"2024","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000866","article-title":"Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders","volume":"31","author":"Takashi","year":"2024","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12891-017-1756-1","article-title":"Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients","volume":"18","author":"Zuo","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0552","article-title":"Tumor-induced osteomalacia: experience from three tertiary care centers in India","volume":"8","author":"Pal","year":"2019","journal-title":"Endocr Connect"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2024.101822","article-title":"Clinical features and treatment of hypophosphatemia and associated complications induced by phosphaturic mesenchymal tumors: a case series of six patients","volume":"24","author":"Lai","year":"2024","journal-title":"Bone Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2026.1814853","article-title":"Tumor induced-osteomalacia caused by a phosphaturic mesenchymal tumor in the sartorius muscle: a case report","volume":"17","author":"Rymon Lipinska","year":"2026","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-022-06516-6","article-title":"Long-term use of burosumab for the treatment of tumor-induced osteomalacia","volume":"34","author":"Crotti","year":"2023","journal-title":"Osteoporos Int"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/0194599820975432","article-title":"Clinical characteristics and surgical outcomes of sinonasal lesions associated with tumor-induced osteomalacia","volume":"165","author":"Zhu","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-020-05795-1","article-title":"Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation","volume":"32","author":"Horng","year":"2021","journal-title":"Osteoporos Int"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac253","article-title":"Tumor-induced osteomalacia: a systematic review and individual patient's data analysis","volume":"107","author":"Rendina","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-250237","article-title":"Tumour-induced osteomalacia due to residual benign glomangioma","volume":"15","author":"Barai","year":"2022","journal-title":"BMJ Case Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.948449","article-title":"Low frequency of HLA-B27 in ankylosing spondylitis patients from Turkey: insights from the Thrace region","volume":"31","author":"Bulut G\u00f6kten","year":"2025","journal-title":"Med Sci Monit"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1808434\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T04:23:48Z","timestamp":1783916628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1808434\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":33,"alternative-id":["10.3389\/fendo.2026.1808434"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1808434","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"article-number":"1808434"}}